Follow-up of adults with noncritical COVID-19 two months after symptom onset

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3 Guan, 2020, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032 Spinato, 2020, Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection, JAMA, 10.1001/jama.2020.6771 Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 Cecconi, 2020, Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy, J Clin Med, 9, 1548 Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 10.1001/jamainternmed.2020.0994 Carfì, 2020, Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19, JAMA, 324, 603, 10.1001/jama.2020.12603 World Health Organization Fletcher, 1959, Significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population, Br Med J, 2, 257, 10.1136/bmj.2.5147.257 Oken, 1982, Toxicity and response criteria of the eastern cooperative oncology group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014 Haut Conseil de la Santé Publique (HCSP), 2020 Lescure, 2020, Clinical and virological data of the first cases of COVID-19 in Europe: a case series, Lancet Infect Dis, 10.1016/S1473-3099(20)30200-0 Grasselli, 2020, Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy, JAMA, 10.1001/jama.2020.5394 Cummings, 2020, Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study, Lancet Docherty, 2020, Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study, BMJ, 369, m1985, 10.1136/bmj.m1985 Lechien, 2020, Clinical and epidemiological characteristics of 1,420 European patients with mild-to-moderate coronavirus disease 2019, J Intern Med, 10.1111/joim.13089 Menni, 2020, Real-time tracking of self-reported symptoms to predict potential COVID-19, Nat Med, 10.1038/s41591-020-0916-2 Haut Conseil de la Santé Publique (HCSP), 2020 Balfour, 2005, A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis, J Infect Dis, 192, 1505, 10.1086/491740 Horwitz, 1986, Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases, Medicine (Baltimore), 65, 124, 10.1097/00005792-198603000-00005 Wreghitt, 2003, Cytomegalovirus infection in immunocompetent patients, Clin Infect Dis, 37, 1603, 10.1086/379711 Mahase, 2020, Covid-19: what do we know about ‘long Covid’?, BMJ, 370, m2815, 10.1136/bmj.m2815 Xiao, 2020, Survivors of COVID-19 are at high risk of posttraumatic stress disorder, Glob Health Res Policy, 5, 29, 10.1186/s41256-020-00155-2 Dutheil, 2020, PTSD as the second tsunami of the SARS-CoV-2 pandemic, Psychol Med Liu, 2020, Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter, Psychiatry Res, 287, 112921, 10.1016/j.psychres.2020.112921